Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
195TiP GLOW: Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin18.2⁺/HER2⁻ advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
Annals of oncology, 2020-11, Vol.31, p.S1315-S1316
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer
ESMO Gastrointestinal Oncology, 2024-12, Vol.6, p.100095, Article 100095
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A Retrospective Comparison of Neoadjuvant Chemoradiation Therapy Regimens for Locally Advanced Esophageal Cancer
International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E139-E139
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
501TiP Valemetostat and trastuzumab deruxtecan (T-DXd) in previously treated advanced or metastatic human epidermal growth factor receptor 2 (HER2)-positive gastric or gastro-esophageal junction (GEJ) adenocarcinoma
Annals of oncology, 2024-06, Vol.35, p.S200-S200
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
2262P Baseline-informed versus tumor-agnostic minimal residual disease (MRD) concordance study in patients with HER2+ gastroesophageal adenocarcinoma patients
Annals of oncology, 2023-10, Vol.34, p.S1163-S1163
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Prevalence and Significance of Indeterminate Hepatic and Pulmonary Lesions in Patients with Localized Pancreatic Adenocarcinoma
International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S331-S332
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
75MO Health-related quality of life (HRQoL) in FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer (G/GEJC): Results from the FIGHT trial comparing bemarituzumab (BEMA) + modified FOLFOX6 (mFOLFOX6) to placebo (PBO) + mFOLFOX6
Annals of oncology, 2022-11, Vol.33, p.S1460-S1461
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1221P Health-related quality of life (HRQoL) in FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer (G/GEJC): Results from the FIGHT trial comparing bemarituzumab (BEMA) + modified FOLFOX6 (mFOLFOX6) to placebo (PBO) + mFOLFOX6
Annals of oncology, 2022-09, Vol.33, p.S1107
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Patient-Reported Outcome Measures during Chemoradiotherapy for Esophageal Cancer and Relationship with Pathologic Response
International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e33-e33
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
135MO Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
Annals of oncology, 2023-11, Vol.34, p.S1524-S1525
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
134MO Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab + CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
Annals of oncology, 2023-11, Vol.34, p.S1524
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
LBA81 Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab + CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
Annals of oncology, 2023-10, Vol.34, p.S1321-S1321
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
LBA82 Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma
Annals of oncology, 2023-10, Vol.34, p.S1322-S1322
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
Annals of oncology, 2011-06, Vol.22 (6), p.1367-1373
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1416P Genomic landscape of late-stage gastric cancer
Annals of oncology, 2021-09, Vol.32, p.S1062-S1063
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
198TiP SPOTLIGHT: Phase III study of zolbetuximab + mFOLFOX6 versus placebo + mFOLFOX6 in first-line Claudin18.2⁺/HER2⁻ advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
Annals of oncology, 2020-11, Vol.31, p.S1317-S1317
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer
Annals of oncology, 2018-10, Vol.29, p.viii268-viii269
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Biomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER2+ gastric adenocarcinoma (GEA)
Annals of oncology, 2018-10, Vol.29, p.viii223-viii223
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
Annals of oncology, 2020-09, Vol.31, p.S1192-S1193
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
Annals of oncology, 2009-03, Vol.20 (3), p.475-480
2009
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods
European radiology, 2020-02, Vol.30 (2), p.1062-1074
2020
Volltextzugriff (PDF)
1 – 21 von 21
Suche als RSS-Feed
Aktive Filter
SpracheEnglisch
Suchergebnisse filtern
Filter anzeigen